Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence